14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Jun 23, 2020 $6.89 $6.89 $6.33 $6.75 737 453
Jun 22, 2020 $6.31 $6.39 $5.81 $6.36 429 201
Jun 19, 2020 $5.55 $6.24 $5.54 $6.16 546 403
Jun 18, 2020 $5.39 $5.79 $5.39 $5.63 234 562
Jun 17, 2020 $5.45 $5.74 $5.28 $5.43 347 895
Jun 16, 2020 $5.50 $5.50 $5.15 $5.46 326 644
Jun 15, 2020 $5.01 $5.25 $4.89 $5.14 287 228
Jun 12, 2020 $5.01 $5.34 $4.80 $5.02 363 665
Jun 11, 2020 $5.40 $5.69 $4.84 $4.85 365 373
Jun 10, 2020 $5.28 $5.76 $5.21 $5.61 392 768
Jun 09, 2020 $5.24 $5.48 $5.15 $5.23 497 097
Jun 08, 2020 $5.30 $5.33 $5.17 $5.22 1 196 151
Jun 05, 2020 $5.08 $5.44 $5.04 $5.22 445 884
Jun 04, 2020 $4.93 $5.10 $4.92 $5.10 306 899
Jun 03, 2020 $5.12 $5.14 $4.81 $4.90 267 170
Jun 02, 2020 $4.78 $5.10 $4.78 $4.98 252 482
Jun 01, 2020 $4.82 $4.95 $4.72 $4.78 278 513
May 29, 2020 $4.81 $4.85 $4.60 $4.80 200 517
May 28, 2020 $5.13 $5.22 $4.75 $4.83 354 406
May 27, 2020 $5.35 $5.35 $4.82 $5.03 461 632
May 26, 2020 $4.71 $5.09 $4.71 $5.02 628 852
May 22, 2020 $4.47 $4.60 $4.42 $4.60 217 373
May 21, 2020 $4.40 $4.50 $4.21 $4.48 181 175
May 20, 2020 $4.38 $4.38 $4.27 $4.35 289 486
May 19, 2020 $4.23 $4.29 $4.10 $4.20 195 195
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT